DRUG-RESISTANT 'NIGHTMARE BACTERIA' ON RISE IN U.S.: CDC REPORT, Pg 14.

Key Highlights:

• A CDC report published in the Annals of Internal Medicine on Monday revealed a rise in drug-resistant bacteria in the U.S.
• The increase is primarily driven by bacteria with the NDM gene, which are difficult to treat.
• Only two expensive antibiotics, administered via IV, are effective against these NDM gene infections.
• Misuse of antibiotics and increased antibiotic use during the COVID-19 pandemic are contributing factors.

Detailed Insights:

• Many individuals may unknowingly carry these drug-resistant bacteria, potentially leading to community spread.
• Common infections like urinary tract infections could become harder to treat due to this resistance.
• Antimicrobial resistance occurs when germs develop the ability to resist drugs designed to kill them.
• The CDC's data represents a partial picture due to incomplete testing and reporting in many states, focusing on severely ill hospital patients.

Key Concepts Involved:

• Antimicrobial Resistance: The ability of microbes to resist the effects of drugs designed to kill them.
• NDM Gene: A gene that makes bacteria resistant to many antibiotics; New Delhi Metallo-beta-lactamase.